Kim Janda serves as Executive at Sorrento Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Kim Janda has executed 10 insider transactions totaling $466.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 27, 2021 involved selling 3,000 shares valued at $17.6K.
Kim Janda currently holds 3,000 shares of Sorrento Therapeutics, Inc. (SRNE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kim Janda has been a net seller of SRNE stock. They have purchased $0 and sold $466.2K worth of shares.
Kim Janda's most recent insider trade was on Dec 27, 2021, when they sold 3,000 shares at $5.88 per share.
Get notified when new Form 4 filings are submitted
| $4.00 |
| Discretionary |
| Sep 27, 2021 | SRNE | $339.7K | Sale | 42,357 | $8.02 | Discretionary |
| Sep 27, 2021 | SRNE | $26.3K | Option Exercise | 7,357 | $3.57 | Discretionary |
| Sep 27, 2021 | SRNE | $63.0K | Option Exercise | 35,000 | $1.80 | Discretionary |
| Sep 13, 2021 | SRNE | $28.0K | Option Exercise | 8,000 | $3.50 | Discretionary |
| Sep 13, 2021 | SRNE | $64.3K | Sale | 8,000 | $8.04 | Discretionary |
| Apr 12, 2021 | SRNE | $6.7K | Option Exercise | 1,900 | $3.50 | Discretionary |
| Apr 12, 2021 | SRNE | $13.2K | Sale | 1,900 | $6.97 | Discretionary |
| Mar 15, 2021 | SRNE | $31.3K | Sale | 3,000 | $10.42 | Discretionary |